|

GZR-33 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Gan and Lee Pharmaceuticals, USA1

Indications

  • Type 1 Diabetes Mellitis1
  • Diabetes1

Other1 trial

Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.